In press) suggest that EGR1 may be an important signaling molecule for regulating levels of migration and adhesion molecules during humoral immune responses.
Summary
In press) suggest that EGR1 may be an important signaling molecule for regulating levels of migration and adhesion molecules during humoral immune responses.
A ntigen-specific activation of B lymphocytes is a complex process initiated by signals generated through the B cell antigen receptor (BCR) 1. BCR signaling involves a series of increasingly well-defined biochemical events resulting in alterations of gene expression and subsequent changes in the phenotypic and activation state of the B cell (1) . Although necessary to initiate the B cell response, in most cases BCR-generated signals are insufficient to drive later activation events such as proliferation and differentiation into antibody-secreting cells (2) . For these later events, antigen-stimulated B cells require contact-dependent signals delivered by T cells. These contact-dependent second signals involve ligand-receptor interactions between molecules expressed on the antigen-stimulated T and B cells (2) .
1Abbreviations used in this paper: BCR, B cell antigen receptor; CAT chloramphenicol acetyl transferase; EMSA, electrophoretic mobility shift assay; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ICAM-1, lntracellular adhesion molecule 1; PAP, placental alkaline phosphatase.
Molecules on the B cell that may be involved in costimulation with BCR signals include CD40 and MHC class II antigens, which interact with T cell surface proteins CD40 ligand (gp39) and TCR/CD4, respectively (3, 4) . Additional paired proteins on the antigen-activated B and T cells function primarily to stabilize the physical interaction between these cells. These adhesion molecules may initiate some costimulatory function as well (5, 6) . One of these cell adhesion molecules is intercellular adhesion molecule (ICAM) 1/CD54. ICAM-1 is the prototypic member of a family of hgands for the [3-2 integrin LFA-1. This family also includes ICAM-2 and ICAM-3, although ICAM-I is thought to play the predominant role in B cell-T cell interactions (7, 8) . Besides mediating interactions between B and T cells, ICAM-1-LFA-1 interactions have also been implicated in B lymphocyte homotypic adhesion (9) . Expression of ICAM-1 on B lymphocytes is upregulated by stimulation. For example, stimulation ofB lymphocytes by BCR cross-linking results in an increase in cell surface ICAM-1 levels (11, 12) . In endothelial cells, induced increase in ICAM-1 expression is the result of elevated transcription of the Icarn-I gene (13, 14) .
Although transcriptional induction of the Icam-I gene by BCR cross-linking can be inferred from other studies (11, 12) , the molecular processes involved in linking this gene to antigen receptor-initiated signaling events have not been analyzed, nor have the transcriptional control elements for Icam-t in B ceils been studied. Analysis of the human Icam-I promoter revealed a number of potential binding sites for inducible and constitutively expressed transcription factors, including NF-KB, SP1, and EGR1. In this study, we provide evidence that a B cell line that lacks EGR1 expression is also compromised in its abi/ity to upregnlate (12) . EGR1 has been shown to be a transcriptional activator both in lymphocytes (20) and other cell types (21, 22) . A growing number of EGRl-regnlated genes in fibroblasts, neurons, and kidney have been described (23) (24) (25) (26) . Interestingly, although egr-I expression is a common component of the inducible immediate-early gene response in nearly all cells studied, the majority of the EGRl-regulated genes so far identified have been tissue specific or restricted (27, 28) .
Based on the association of EGR1 with BCR activation (i9), its transcriptional regulatory activity (20--22), the kinetics of its expression relative to Icam-1, and our preliminary studies in EGRl-expressing and -nonexpressing B cells, we considered EGR1 as a possible regulator of 1cam-I induction after BCR cross-linking. This hypothesis was tested in these studies.
Materials and Methods
Isolation of Murine B Lymphocytes, Cell Culture, and Flow Cytometry. The WEHI-231 B cell lymphoma (American Type Culture Collection, RockviUe, MD) and all limiting dilution subclones including WEHI-231.7 and WEHI-231.1F1 were maintained in DME, high glucose supplemented with 10% FCS (Hyclone, defined; Hyclone Laboratories Inc., Logan, UT), SerExtend (Hana Biologicals, Berkeley, CA), 2 mM t-glutamine, nonessential amino acids (GIBCO/BRL, Gaithersburg, ME)), and 5 X 10 -s M 2-ME. Cells were maintained at a minimum and maximum density of 104 and 5 X 10S/m1, respectively. B lymphocytes were isolated from spleens of BALB/c mice as previously described (29) . Briefly, spleens were ground between the frosted ends of two glass slides to produce single cell suspensions. After depletion of T cells by treatment with anti-Thyl.2 antibody and complement and red blood cells by lysis with Gey's solution, the remaining cell suspension was centrifuged over a 75% Percoll cushion, and the interface was collected. This treatment results in a population of >90% IgM+B220 + cells. Cells were then incubated at 37~ 5% COz, for 72 h in B cell assay media (RPMI 1640 supplemented with 10% FCS, 2 mM t-glutamine, nonessential amino acids, 100 Ixg/ml penicillin, 100 I.cg/ml streptomycin, and 5 X 10 -5 2-ME) and 50 /Lg/ml LPS (Sigma Chemical Co., St. Louis, MO).
Flow cytometric analysis was carried out exactly as described (30) using FITC anti-mouse I~ F(ab')2 (PharMingen, San Diego, CA) on a FACScan flow cytometer with LYSIS II software (Becton Dickinson & Co., Mountain View, CA).
Plasmids and Constructs. pBluelCAM containing the flail-length ICAM-1 cDNA in the EcoRI site of pBluescript SK* (Stratagene Inc., La JoUa, CA) was provided by Dr. A. Brian (La Jolla Cancer Research Foundation, La Jolla, CA). pGAPDH contains the full-length murine glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA and was provided by Dr. M. Prystowsky (Albert Einstein School of Medicine, Bronx, NY). The plasmid containing the murine c-myc cDNA was obtained from American Type Culture Collection. The empty expression vector pBX and pBXEGR1 containing the full-length EGR1 cDNA driven by the SV40 promoter have been described (20). pSV2PAP, containing the gene for placental alkaline phosphatase (PAP), was kindly provided by Dr. T. Kadesch (University of Pennsylvania).
pBLICAM and pBLmlCAM contain 1.1 kb of the murine ICAM-1 5' flanking region including its transcription start site. A 1.t-kb BsiHKAI fragment spanning -1091 to +34 was excised from El0 (31), blunt ended with T4 polymerase, and cloned into the PstI site of the promoterless chloramphenicol acetyl transferase (CAT) vector pBLCAT2.3 (32) . For construction of pBLmlCAM, splicing overlap PCR (33) was used to mutate the EGRl-binding site located at -701 bp. The oligonucleotides used were 5'-GAGGCATATGGGCGGGAGC-3' and 5'-CCG-CCCATATGCCTCGGTTCC-3'. Presence of the mutation was confirmed by sequencing using a Sequenase 2.0 kit (USB, Cleveland, OH) according to the manufacturer's instructions.
RNA Isolation and Northern Blot Analysis. Cells were brought to a concentration of 5 • 10S/ml in fresh 37~ media and then equilibrated for I-2 h at 37~ 5% CO2. A~er preincubation, 10 ng/ml PMA, 10 ~g/ml goat anti-mouse tz F(ab')2 (Chemicon International Inc., Temecula, CA), or 50 I~g/ml rabbit antimouse IgM F(ab')2 was added as indicated in the text, and total RNA was isolated using the acid guanidinium thiocyanate-phenol-chloroform method (34) . Equal amounts of RNA were electrophoresed on a 12% formaldehyde-agarose gel and blotted to nylon membranes (GeneScreen Plus; DuPont/NEN, Boston, MA), fixed by UV irradiation, and baked for 2 h at 80~ in a vacuum oven. cDNA probes were labeled using incorporation of [32p}dCTP by nick translation (GIBCO BILL) according to the manufacturers instructions. At~er a I-6 h prehybridization in 50 mM Pipes (pH 6.8), 50 mM NaPO4, 100 mM NaCI, 1 mM EDTA, and 5% SDS at 65~ denatured probe was added, and hybridization was carried out for 12-16 h at 65~ Blots were washed at 65~ for 3 X 20 rain with 1 • SSC and 5% SDS, 3 • 20 rain with 0.5)< SSC and 0.1% SDS, and 3 • 20 rain with 0.2)< SSC and 0.1% SDS. Quantitative analysis was carried out using a Phosphorlmager and lmageQuant software (Molecular Dynamics, Sunnyvale, CA).
Nuclear Run-On Transcription Assays. Exponentially growing cells were aliquotted into 50-rrd conical tubes and equilibrated at 37~ 5% CO2 for 2 h and stimulated with 10 ng/ml PMA. At the indicated times, cells were pelleted, washed twice with PBS at 4~ and lysed in 1 ml oflysis buffer (10 mM Hepes, pH 8.5, 1.5 mM MgC12, 1.0 mM dithiothreitol, 2 mM PMSF, and 1.5 Ixg/ml each of pepstatin A, chymotrypsin, leupeptin, and antipain) on ice for 15 min. After one wash in lysis buffer, nuclei were resuspended in 1 ml oflysis buffer with 10 I~g/ml RNase A for 30 min at 4~ to remove cytoplasmic RNA. Nuclei were then washed twice in lysis buffer at 4~ and resnspended at 107 nuclei/100 IxL in NSB (50% glycerol, 0.02 M Tris-Cl, pH 7.9, 0.075 M NaCI, 0.5 mM EDTA, 0.85 mM dithiothreitol, 0.125 mM PMSF), placed into a dry ice/EtOH bath for 20 min and stored at -70~ Run-on transcription was carried out at 26~ for 10 min in a 200-txL volume with reaction buffer (29% glycerol, 100 mM Tris-C1, pH 7.9, 50 mM NaC1, 4.0 mM MnC12, 1.2 mM dithiothreitol, 0.1 mM PMSF, 0.4 mM EDTA, 1.0 mM nucleoside triphosphates, 10 mM phosphocreatine, 40 U RNAsin (Promega Corp., Madison, WI), 2.5 I.zM UTP, and 200/,~Ci [32p]UTP) followed by addition of 1.5 U RNase-free DNase (Boehringer Mannheim Corp., Indianapolis, IN) and incubation at 26~ for an additional 5 rain. Reactions were terminated by addition of 1 rrd of guanidinium thiocyanate-phenol-NaOAc, pH 4.0, and RNA was extracted as described (35) . Unincorporated nudeotides were removed by two successive NH4OAc (2.5 M)/EtOH precipitations. Prehybridized Genescreen Plus membranes (DuPont/NEN, Boston, MA) containing 5 lxg of denatured pBluescript SK + with or without inserts containing murine ICAM1 (pBIuelCAM) or murine GAPDH (pGAPDH) were hybridized for 65 h at 42~ with 1.2 • 107 cpm of nuclear run-on products in I ml of 50% forrnamide, 5• SSC, 50 mM NaPO4, pH 7.0, 0.1% NaPPi, 1% SDS, 1 mg/ml heparin, and 100 Ixg/ml sheared herring sperm DNA. Membranes were washed for 15 min at 22~ (2• SSC, 0.1% SDS) and 15 min at 68~ (0.1• SSC, 1% SDS). Quantitative analysis was performed as described above.
Electrophoretic Mobility Shift Assays. Exponentially growing cells were stimulated with 10 ng/ml PMA for 2 h, washed twice in PBS at 4~ and nuclear extracts were prepared as described elsewhere (36, 37) . The probe containing the BsaHI/DdeI fragment spanning -657 through -747 bp was labeled using T4 polynucleotide kinase according to the manufacturer's instructions (New England Biolabs, Inc., Beverly, MA) and purified on a 9% native polyacrylamide gel. Binding reactions were carried out in a 20-1xl volume containing 10,000 dpm labeled probe, nuclear extract containing 10 ~g of protein, 1 ~g poly (dI-dC)-poly(dl-dC) (Pharmacia Biotech Inc., Piscataway, NJ), 10 mM Tris, pH 7.5, 40 mM NaC1, 1 mM EDTA, 1 mM 2-ME and 4% glycerol with or without competing oligonucleotides as indicated in the text. For antibody-blocking experiments, antisera specific for either EGR1 or CDK4 (Santa Cruz Biotechnology, Santa Cruz, CA) were preincubated with nuclear extract and poly (dI-dC)-poly(dI-dC) for 15 rain at room temperature. After addition of reaction buffer and labeled probe, the reaction was allowed to proceed for an additional 15 rain at room temperature. Reactions were loaded onto a 4% polyacrylamide gel in 0.5• TBE (1• TBE is 100 rnM Tris base, 89 mM boric acid, 2 mM EDTA) and electrophoresed at 120 V at room temperature. Double-stranded oligonucleotides containing consensus binding sites for AP1 (5' CGCTTGATGAGTCAGCCGGA 3') and SP1 (5' ATTCGATCGGGGCGGGGCGAGC 3') (Promega Corp.), as well as consensus EGR1 (5' GGATCCAGCGGGGGC-GAGCGGGGGCGA 3') and mutant EGR1 (5' GGATCCAGC-TAGGGCGAGCTAGGGCGA 3'), the latter of which fails to bind to murine and human EGR1, were purchased from Santa Cruz Biotechnology.
Tram'lent Transfections, CA T Assays, and PAP Assays. For transient transfections of WEHI-231, cells were grown to 4-5 X 105 cells/ml in media supplemented with 100 U/ml penicillin and 100 Izg streptomycin (supplemented WEHI-231 media). 107 cells were washed once in STBS (25 mM Tris-Cl, pH 7.4, 137 mM NaC1, 5 mM KCI. 0.6 rnM Na2HPO4, 0.7 mM CaC12. and 0.5 mM MgCI2) and resuspended in 1.5 ml of 1X STBS, 0.5 mg/ml DEAE--dextran (Pharmacia Biotech Inc.), and the indicated plasmid DNA. After a 30 min incubation at room temperature, cells were washed once in STBS and resuspended at 2.5 • 105 cells/ ml in fresh supplemented WEHI-231 media. Cultures were divided and stimulated 28 hafer transfection. After a 14-h stimulation, cells were harvested and assayed for CAT as described (32) .
To control for transfection efficiency, cells were cotransfected with pSV2APAP expressing alkaline phosphatase, and enzymatic activity was determined as described (38) .
Primary lymphocytes were transfected as described (29) . Briefly, 2.5 • 107 LPS-blasted cells were washed once in STBS and resuspended at 107 cells/ml in STBS containing 500 ~g/rnl DEAEdextran and the indicated plasmid DNA for 30 min at 37~ Cells were then washed once in STBS and resuspended at 5 • 106 cells/ml in fresh B cell assay media and incubated at 37~ 5% CO2. After 24 h, cells were split into two equal groups and either left unstimulated or stimulated with 10 ng/ml of PMA. Atier an additional 24-h incubation, cells were harvested and assayed for CAT.
Results

Differential Expression of EGR1 in Subclones of WEHI-23 I.
We have previously reported a clone of the WEHI-231 B cell Line (WEHI-231.7) that does not express egr-I upon anti-it or phorbol ester stimulation (35) . Lack of inducible expression of egr-1 was shown to be due to genespecific DNA methylation in these cells (39) . Immunocytochemical analysis of the parental WEHI-231 cell Line from which WEHI-231.7 was cloned demonstrated cell-tocell heterogeneity with respect to egr-1 expression (Monroe, J.G., unpubLished observations). Therefore, a subsequent WEHI-231 clone was derived (WEHI-231.1F1) in which egr-I was expressed at both the message and protein levels after anti-it or phorbol ester stimulation.
As shown in Fig (35, 39) . It is important to note here that as far as we have been able to ascertain, the observed difference in BC1L-and PMA-induced egr-1 in these fines relates to gene-specific transcriptional silencing (39) and is not associated with quantitative differences in BCR. expression or signaling. Both Lines exhibit comparable sIgM expression levels (Fig. 2 A) and undergo anti-itand PMA-induced growth arrest (Maltzman, J.S., andJ.G. Monroe, unpublished data). Furthermore, the difference seen in egr-I message is not representative of a generalized 1 and 4) or were stimulated for 1 h with either 10 ng/ml PMA or 50 Ixg/ml rabbit anti-mouse p. F(ab')2. Total cellular RNA was size fractionated by electrophoresis through 1.2% agarose-formaldehyde gel, transferred to GeneScreen Plus membranes, and hybridized simultaneously with 32p-labeled probes for egr-I and GAPDH as described in Materials and Methods.
inability to induce immediate-early gene expression, since the expression o f other transcription factors encoded by immediate-early genes such as c-myc (Fig. 2 /3 ) and egr-2/ krox-20 (data not shown) does not differ between these two lines. Thus, although we are unable to formally exclude the possibility that W E H I -2 3 1 . 7 and WEHI-231.1F17 (hereafter referred to as 231.7 and 1F1, respectively) may differ in parameters other than egr-1 inducibility, this pair of related and otherwise phenotypically similar ceils affords us the opportunity to identify genes whose transcription is regulated directly or indirectly by EGR1. W e reasoned that B C R -i n d u c e d genes that require E G R I expression for 
Induction of Icam-1 Gene Expression is Associated with E G R 1 Expression in IF1 and 23 I. 7 Cells.
For the reasons discussed previously, we considered Icam-1 to be a potential target of regulation by EGR1. Consistent with this possibility, anti-I* stimulation of the E G R l -n o n e x p r e s s i n g line (231.7) failed to induce increased lcam-1 m R N A expression (Fig. 3 A) . Failure to induce expression of Icam-1 m R N A contrasted with the response observed in the EGRl-expressing subclone 1F1, in which we observed induction of Icam-I m R N A by 2 h after stimulation with anti-l*. Induction by anti-l* was small (~2-fold at 2 h), but this induction was significantly different (P <0.01) than that seen in 231.7 cells across four independent experiments (Fig. 3 A, right) . Bypassing the B C R by stimulating the cells with P M A also resulted in Icam-1 induction in 1F1 but not the egr-/-nonexpressing line 231.7 (Fig. 3 B) . The results o f this latter experiment were quantitated and are presented in Fig. 4 A. The rate of transcription initiation of Icam-1 was increased at 1 h (relative to unstimulated controls) after stimulation of 1F 1 ceils. The rate of transcription began to decrease by 2 h and was down to basal levels by the 3-h time point, consistent with the kinetics observed by Northern blot analysis (Fig. 3) . To quantitatively compare the induction of Icam-1 transcription between 1F1 and 231.7, identical analyses were performed using 231.7 nuclei, and band intensities were quantified and normalized to levels of transcription of the housekeeping gene encoding G A P D H . The results of these analyses are expressed graphically in Fig. 4 B. As indicated, stimulation of 1F1 cells led to a sevenfold increase in transcription at 1 h compared with a threefold increase in 231.7 cells. These results indicate that the differential levels of induction seen at the steady state level by Northern blot analysis are due at least in part to differences in the rate o f Icam-1 transcription, consistent with E G R l -d e p e n d e n t regulation. It is not obvious how differences in the level of inducibility as measured by Northern blot analysis (Fig. 3 B ; 16-fold) and transcription initiation are to be reconciled. Often, the levels measured by these two assays are not identical; run-ons routinely show less induction than Northern blot analysis. This difference may reflect characteristics of the assay systems themselves, that is, efficiency and sensitivity or, in some cases, suggest a degree of posttranscriptional regulation in the induced cells. The critical point in this analysis, however, is the clear evidence of transcriptional induction of lcam-I in 1F1 and the elevated induction in 1F1 cells compared with that observed in 231.7 B cells.
E G R 1 Binds to a Consensus Motif at -7 0 1 bp qf the Murine lcam-1 Promoter. Sequence analysis of the human Icam-1 promoter suggested two potential E G R l -b i n d i n g motifs at -6 9 3 bp and -6 9 9 bp. At the onset of these studies, the sequence of the murine promoter had not been extended beyond -6 6 0 bp (31), and therefore could not be evaluated for the presence of these potential regulatory motifs. Further sequencing of the murine 5' region and analysis of the region between -6 6 0 and -1 0 9 1 bp identified a single consensus E G R l -b i n d i n g motif at -7 0 1 bp, an AP2 motif at -8 8 3 bp, an NF-~13 motif at -8 7 0 bp, and two SP1-binding motif~ at -7 0 0 and -9 5 5 bp (shown schematically in Fig. 5 A) .
To determine if murine E G R 1 protein binds to the m otif at -7 0 1 bp, nuclear extracts isolated from stimulated 1F1 cells were used as a source of cellular E G R 1 protein in electrophoretic mobility shift assays (EMSAs). Competition EMSA analysis was carried out using a radiolabeled 90-bp probe spanning the region from -7 4 7 to -6 5 7 bp (Fig. 5  A) . Addition of nuclear extracts from stimulated 1F1 cells resulted in multiple shifted complexes (Fig. 5 B, lane 1) . Figure 4 . Differential induction of lcam-1 transcription initiation in 231.7 and 1F1 cells, (A) Nuclei were isolated from 1F1 cells that had been stimulated with 10 ng/ml PMA for 0, 1, 2, 3, or 4 h and used as templates to produce 32p labeled nuclear run-on transcription probes as described in Materials and Methods. 5 I~g each of pBluescript SK + vectors containing either loam-I, GAPDH, or no insert were immobilized onto GeneScreen Plus membranes. The run-on transcription products were hybridized to the membranes. (B) Quantitative analysis of PMA-stimulated loam-t transcription in 231.7 and 1F1 cells was performed using a Phosphorlmager. lcam-1 band intensities from the hybridized filters from A and a simultaneous experiment using nuclei from PMA-stimulated 231.7 cells were quantitated and normalized to GAPDH intensities at each time point. The results are expressed as fold induction versus unstimulated levels.
Competition with oligonucleotides containing two consensus E G R l -b i n d i n g motifs (ERE), but not mutated EGR1 binding motifs (mERE), resulted in dose-dependent competition of a single intermediate-sized complex (Fig, 5  B, compare lanes 2 and 3 with 1 and 4) .
The potential E G R l -b i n d i n g site at -7 0 1 bp is associated with an overlapping SP1 site. Therefore, the slower mobility complex present in the lanes containing extracts from either 231.7 or 1F1 cells was considered to be SP1, This conclusion was confirmed by experiments shown in Fig. 5 B in which ohgonucleotides containing a consensus SPl-binding motif specifically competed for the slower complex mobility (Fig. 5 B, compare lanes 1 and 5) . C o nversely, oligonucleotides containing an APl-binding motif did not compete for binding of any of these complexes (Fig. 5 B, compare lanes I and 6) , confirming the sequence specificity of these complexes.
To confirm that the complex competed by unlabeled EGR1 oligonucleotides contained EGR1 and not a related family member, two types o f experiments were performed. First, addition of rabbit antiserum specific for a C O O Hterminal region of the EGR1 that is not shared by other E G R family members (40) (41) (42) (43) resulted in a specific supershift of the intermediate mobility complex that was previously shown to be disrupted by competition with unlabeled E G R 1 -but not SPl-binding sites (Fig. 5 C) . In contrast, a control rabbit antiserum did not supershift or disrupt the complex. In a second type of experiment, nuclear extracts from stimulated and unstimulated 231.7 and 1F1 cells were compared (Fig. 5 D) . If the protein participaring in formation of the intermediate mobility complex is EGR1, then this complex would be expected to be unique to 1F1 nuclei (compared with 231.7) and also should be more abundant in stimulated extracts. In comparison, since SP1 is a ubiquitously expressed transcription factor (44), its binding activity should be observed in both subclones. As shown in Fig. 5 D, the EGR1 complex is unique to the 1F1 cells, and its abundance increases with stimulation. In addition, the slow mobility complex identified as SP1 by competition experiments is present in both cell lines regardless o f stimulation (Fig. 5 D) . In contrast to E G R I , increased binding o f SPl after stimulation o f 1F1 cells is not a reproducible finding in our hands.
Involvement of the -701-bp EGRl-binding Site in Icam-1 Induction.
The above studies have identified a potential E G R l -b i n d i n g site in the 5' lcam-1 promoter and demonstrated the ability of this site to bind to EGR1. To determine whether this site is important for the transcriptional regulation o f Icam-1 in anti-w-and PMA-stimulated B lymphocytes, we mutated this site in the context o f the entire Icam-1 promoter. Reporters containing either 1.1 kb of the murine Icam-1 promoter ( -1 0 9 1 -+ 3 4 bp) upstream of the C A T reporter gene (pBLICAM), or a variant derived by site-directed mutagenesis o f the E G R l -b i n d i n g site at -7 0 1 bp (pBLmlCAM) were constructed (see Fig. 7 A) . The mutation within the pBLmlCAM construct consists of a 5-bp substitution that abolishes the ability of EGR1 to bind to the -7 0 1 -b p site but, importantly, retains SPlbinding activity as determined by EMSA (data not shown). To test the effect of this mutation on the ability to induce lcam-I gene expression in anti-I~-and PMA-stimulated B cells, we exploited the use of the LPS blast transfection system that we have previously described (29) . The strength o f this is that it allows us to analyze inducibility in a nontransformed primary B cell; caveats associated with transformation of established tissue culture lines are thus avoided. Importantly, both Icam-1 and egr-1 are inducible by PMA and anti-I~ in the LPS blast system (Fig. 6) .
B lymphocytes, transiently transfected with either pBL- (Table 1) or P M A ( Fig. 7 and Table  1 ). The level o f basal C A T activity from unstimulated cells was approximately equal whether the E G R 1 motif was intact or mutated (Fig. 7 B) . (Table 1) . Importantly, although induction by anti-g, stimulation is less than that observed for PMA, mutation o f the defined E G R l -b i n d i n g site nonetheless abrogated induced levels o f transcriptional activity by 48-68% across three separate experiments (Table 1) . From these studies, we can conclude that the -7 0 1 -b p E G R l -b i n d i n g motif is required for the full induction o f the Icam-1 promoter.
Exogenous E G R 1 Transactivates the Icam-1 Promoter.
The above results show that the E G R 1 motif (independent o f the overlapping SP1 motif) is necessary for full activation o f the Icam-1 promoter in a n t i -~-or PMA-stimulated B cells. (Fig. 8 B, solid bars) , we observed a dose-dependent increase in Icam-1 promoter activity associated with increasing amounts of E G R 1 expression vector.
In the above case, E G R 1 could be acting directly or indirectly through this promoter. However, we believe that this effect is mediated by direct effects o f E G R 1 on the Icam-1 promoter because mutation o f the -7 0 1 -b p E G R 1 -binding site completely abrogates the E G R l -m e d i a t e d transactivation (Fig. 8 B, hatched bars) . Therefore, the transactivation studies clearly establish the ability of E G R 1 to Figure 6 . BCR cross-linking and PMA stimulation induce lcam-I and egr-1 mRNA in LPS blasts. Purified splenic B lymphocytes were stimulated for 72 h with 50 p.g/ml of LPS. Cells were washed twice with PBS and cultured for an additional 24 h in the absence of LPS. Cells were then stimulated with either 10 ng/ml PMA (lanes 1-5) or 10 i~g/ml of F(ab')2 fragments of goat anti-mouse I~ (lanes 6-10) for the times indicated above each lane. Equivalent amounts of RNA were size fractionated, transferred to a GeneScreen Plus membrane, and hybridized with 32p labeled cDNA probes for Icam-1 (A, top) . The membrane was stripped and simultaneously reprobed for egr-1 and GAPDH (A, bottom). The relative locations of 28S and 18S rRNA are indicated to the right. (B) The levels of lcam-1 mRNA expression were quantitated and normalized to GAPDH expression. Values are presented as fold induction after PMA or anti-p, stimulation relative to unstimulated cells.
induce transcription via the Icam-1 promoter and, furthermore, establish that this effect is most likely to be direct. The observation that mutation o f the lcam-l-associated E G R l -b i n d i n g site abolishes E G R 1 transactivation of this promoter indicates that E G R 1 is not acting indirectly via regulation of another transcription factor.
Discussion
Activation o f B lymphocytes by antigen is a complex process that integrates membrane, cytoplasmic, and nuclear processes into long-term phenotypic and functional changes in the B cell. These activation-associated events regulate the ability of the B cell to present processed antigen to T cells, function as an immune effector cell, and generate antigen-specific memory cells. Transcription factors whose expression is induced after B C R signaling facilitate coupling between receptor-induced second-messenger pathways and the nuclear events that regulate these phenotypic and functional changes. Here we have investigated a single and defined event that is necessary for an antigen-induced immune response (45, 46) . W e have shown that induction of Icam-1 transcription after B C R -i n d u c e d signals is coupled to the B C R via the transcription factor EGR1. In our previous studies, we identified the p21'~/~/MAP kinase pathway as the important signaling pathway linking B C R or phorbol ester stimulation to egr-I gene induction (47) . Taken together, these studies define a role for the p21 r~ pathway and E G R 1 in linking B C R cross-linking to immunologically relevant functional responses in B cells; namely, the upregulation of expression of a gene directly involved in B cell-T cell interaction. Adhesion molecules such as ICAM-1 function to stabilize interactions with T cells during the period in which the B cells manifest a requirement for secondary signals to further promote activation and differentiation of the antigen-stimulated B cell.
The importance of E G R 1 in the induction of Icarn-1 expression after B C R cross-linking is based on several lines of mutually supporting evidence: (a) we have demonstrated that the -7 0 1 -b p E G R l -b i n d i n g site is necessary for the full inducible activity of the Icam-I gene in response to either B C R ligation or in situations in which the receptor is bypassed by stimulation with phorbol ester; (b) B cell lines that differ in their ability to express EGR1 also show differential inducibility of Icam-1 gene expression; and (c) exogenous EGR1 is able to transactivate the Icam-1 promoter, and mutation of the -701-bp E G R 1-binding site abolishes this transcriptional activation. The caveats and interpreta- Experiments represent individual separate experiments using the wildtype and mutant lcam-1 promoter-CAT reporter constructs described in Fig. 7 . Primary B cells (LPS blasts) were transfected with pBLICAM (wild-type) or pBLmlCAM (mutant -701 bp) and stimulated with either PMA (10 ng/ml) or anti-p, antibodies (50 gtg/rnl) as described in Fig. 7 . Results are fold induction relative to umtimnlated control cultures.
tions of each of these conclusions will be discussed in detail below. Figs. 3 and 6 ). We interpret these findings to indicate that whereas BCR-inducible Icam-1 expression is to a large extent dependent upon EGK1, basal or resting levels are regulated by another mechanism. The SP1 site Micrograms of pSXEGR1 may be important for this regulation. As discussed previously, SP1 is a constitutively expressed transcription factor in these cells, and, as shown in the EMSA experiments, it binds to the promoter in the unstimulated cells. Its role in the inducible expression of lcam-1 was not directly evaluated in these studies because the integrity of the SPl-binding site was maintained in the mutations of the -701-bp site. The fact that inducible activity was reduced by 50-75% despite the ability of SP1 to still bind to this site indicates that it is not the major regulator of inducible Icam-1 expression. However, it is still possible that the inducible activity remaining when EGR1 binding is abolished may be due to the intact binding of SP1 to this site. Changes in the levels of SP1 or its posttranslational modification in response to BCR or PMA stimulation may contribute to the activity of the Icam-1 promoter under conditions in which EGR1 is absent or cannot bind. Alternatively, other sites in the promoter may also contribute to the inducible activity of this promoter after BCR or PMA stimulation. For example, an NF-KB-binding motif has been implicated in cytokine-induced Icam-1 expression in human endothelial cells (13, 48, 49) . Regardless of the contributions of either of these mechanisms to the inducible activity of the promoter in the absence of EGR1 binding, our data clearly implicate EGR1 as the major regulator of Icam-1 transcription in BCR-and PMA-stimulated B cells. Before leaving this subject, it could be argued that it is a protein other than EGR1 that binds to the -701 motif and regulates the transcriptional activity of this promoter. Several lines of evidence argue against this possibility, however. First and foremost is the observation that induction of Icam-I is compromised in the 231.7 cells that fail to express EGR1 but do not differ in their expression of the other egr family member (egr-2), which can also bind this site (49a). Secondly, the EMSA analysis of the -701-bp region shown in Fig. 5 identified a single band that was associated with the ability to induce Icam-1 expression (i.e., this band comigrated with a complex associated with the -701-bp site in EGRl-expressing but not -nonexpressing B cells and was specifically blocked with a consensus EGRl-binding site but not a mutated one). Most importantly, the complex associated with this band was shown to be disrupted with antibodies specific to the EGR1 protein. Finally, the transactivation studies establish the ability of EGR1 to activate this promoter through this motif. In the 231.7 EGR1 nonexpressors, even after stimulation with PMA, significant induction required exogenous EGR1 expression. Taken together, these results indicate strong support for our interpretation that EGR1 is the relevant transcription factor in this response.
Because 231.7 B cells do not express EGR1, we were able to perform the transactivation studies using stimulated cells. By doing so, we were not only able to test the ability of EGR1 to transactivate this promoter, but also to establish the importance of EGR1 under conditions in which any other putative induced transcriptional regulators would be present. The observation that significant Icam-1 promoter activity required the expression of EGR1 and that this transactivation depended upon the ability of EGR1 to bind this promoter (i.e., mutation of the -701 site blocked this response) demonstrates three things. First, EGR1 can activate this promoter. Second, the lack of Icam-1 inducibility in 231.7 is not due to a repressor of transcription, because this putative repressor would be expected to inhibit transactivation by the exogenous EGR1 protein. Third, significant promoter activity requires EGR1 even under conditions in which other potential transactivators may be present.
Interestingly, in light of this discussion, when similar studies were performed in unstimulated 231.7 cells, we failed to observe transactivation of the lcam-1 promoter. We conclude, therefore, that stimulation is necessary for transactivation by exogenous EGRI in this system. Although this result does not negate the conclusion relevant to the studies here (i.e., that EGR1 does transactivate this promoter), it does raise some interesting possibilities regarding the mechanism of EGR1 transcriptional regulation. First and less interesting, the requirement for stimulation may reflect the need to stimulate higher levels of transfected EGR1 expression. In this regard, it is well-established that stimulation can increase the activity of the SV40 enhancer. We do not believe that this is the case, however, because we observed similar effects using the 13-actin promoter, which is not affected by PMA or anti-Ix stimulation (data not shown). Also, as alluded to previously, stimulation may induce expression of other cofactors that cooperate with EGR1 in the transcriptional regulation of this promoter (50) (51) (52) . Alternatively, EGRI may require posttranslational processing provided by stimulation, such as phosphorylation, to exert its activation effect (53) (54) (55) . In this regard, it is interesting that the major transactivation domain of EGR1 is rich in extended stretches of serine and threonine residues (20). Phosphorylation of these residues would be expected to impart a net negative charge to this region, and in so doing, possibly convert it from an inactive to active transcriptional activator. EGR1 is phosphorylated on serine residues in fibroblasts stimulated with serum (56) , and this phosphorylation is associated with increased EGR1 transcriptional activity (57, 58) . Evaluating the relative contribution of these effects is a current area of interest in our laboratory.
Identification and use of the 231.7 and 1F1 B cells hnes is a significant accomplishment of these studies. Their use in these studies afforded us two unique advantages over other systems used to evaluate transcription factor-target gene relationships. First (as just discussed), they allowed us the opportunity to carry out transient cotransfection assays in stimulated cells without the expression of endogenous EGR1. By comparing gene regulation in stimulated B cells with and without EGR1, we were able to evaluate the relative importance of EGR1 expression in the presence of other stimulation-associated processes. This level of analysis is not possible in the majority of model systems in which the stimulus would induce expression of the endogenous transcription factor as well as these other potential events. Perhaps even more important, comparisons between 231.7 and 1F1 have allowed us to evaluate Icam-1 regulation by EGR1 at physiological levels of EGR1 (endogenous expression in 1F1) and with the Icam-1 gene in its normal chromosomal context. Whereas transient assay systems as used in the majority of published studies allow for detailed deletion/mutation mapping of promoter elements, the DNA reporters used in these studies lack the constraints imposed by chromosome structure, which hmits the interpretation of studies relying fully on this type of experiment.
The 231.7/1F1 system offers the opportunity to examine the involvement of EGP,,1 on regulation of endogenous genes. The combination of transient expression data and endogenous gene regulation makes this a unique system for studies of EGRl-regulated genes. Importantly, the cell line studies are further strengthened by the LPS blast system, which has allowed us to confirm and extend these studies using a nontransformed B cell model.
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